Enzymatic Resolution of 1,4-Cineole Derivatives

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current processes for preparing optically active 1,4-cineole derivatives and 7-oxabicyclo[2.2.1]heptane derivatives suffer from low enantiomeric excess and poor yields, leading to loss of precious material and unsatisfactory optical purity, which is critical for herbicidal activity.

Innovation Solution

An enzymatic resolution process using a hydrolase enzyme for acylating a mixture of 1,4-cineole derivatives, followed by preferential crystallization to achieve enantiomerically pure compounds with greater than 99.9% enantiomeric excess, allowing for the preparation of 7-oxabicyclo[2.2.1]heptane derivatives with high purity without compromising yield.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional processes are used for preparing optically active 1,4-cineole derivatives, then the production can proceed with standard methods, but the enantiomeric excess is low and the yield is poor

Engineering Contradiction:
Improveenantiomeric excessVSAvoidyield
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent applies parameter changes by modifying the enzymatic reaction conditions, including using specific hydrolase enzymes, controlling temperature, pH, and substrate concentration, to achieve both high enantiomeric excess (>99.9%) and high yield simultaneously in the resolution of 1,4-cineole derivatives

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses hydrolase enzymes as intermediaries to catalyze the selective hydrolysis of racemic 1,4-cineole derivatives, enabling high enantiomeric excess separation while maintaining high productivity through efficient enzymatic catalysis

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If conventional processes are used for preparing optically active 1,4-cineole derivatives, then standard production methods can be applied, but the optical purity is unsatisfactory

Engineering Contradiction:
Improveoptical purityVSAvoidmaterial loss
Core Design Contradiction:
Manufacturing precisionVSLoss of substance

Solution Approach 1:

The patent optimizes reaction parameters including enzyme selection, temperature, pH, and reaction time to achieve optical purity greater than 99.9% while minimizing material loss through efficient enzymatic resolution that converts rather than discards the unwanted enantiomer

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent recovers and recycles the unwanted enantiomer from the resolution process, converting it to the desired enantiomer through enzymatic transformation, thereby minimizing material loss and improving overall yield while maintaining high optical purity

Inventive Principle:
Principle #34Discarding and recovering

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The process effectively achieves enantiomerically pure 1,4-cineole and 7-oxabicyclo[2.2.1]heptane derivatives with high enantiomeric excess, minimizing material loss and improving herbicidal activity by optimizing the enzymatic resolution and crystallization steps.

Implementation Method 1

The invention provides a process for the preparation of an optically active compound of formula (II-R) or (II-S) wherein a mixture comprising a compound of formula (II) is reacted with an acylating agent in the presence of a hydrolase to obtain a mixture containing the first enantiomer of the compounds of formula (II) in acylated form and the second enantiomer of the compounds of formula (II) in unacylated form

Methodology Applied
Scientific EffectEnzymatic resolution: Enzyme

Implementation Method 2

followed by preferential crystallization to achieve enantiomerically pure compounds with greater than 99.9% enantiomeric excess

Methodology Applied
Scientific EffectPreferential crystallization: Crystallisation

Data Source

PatentUS11639358B2Process for preparing an optically active cineole derivative
Publication Date: 2023.05.02 BASF AGRO BV
  • US11639358B2 patent drawing
  • US11639358B2 patent drawing
  • US11639358B2 patent drawing

AI summary

The present invention relates to a process for preparing optically active 1,4-cineole derivatives by enzymatic resolution and enantiomerically pure optically active 1,4-cineole derivatives of purity greater than 99.9% that have been prepared by this process. The present invention further relates to a process for preparing 7-oxabicyclo[2.2.1]heptane derivatives from the enantiomerically pure optically active 1,4-cineole derivatives.